Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George J Netto

Showing results (271-280 of 315) with videos related to

Pageof 32
Sort By:
Archives of Pathology & Laboratory Medicine|August 4, 2006
Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experienceGeorge J Netto, David L Watkins, James W Williams, et al.
Histopathology|June 27, 2022
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancerJames G Kench, Mahul B Amin, Daniel M Berney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2010
A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancerAndrew J Armstrong, George J Netto, Michelle A Rudek, et al.
The Lancet. Oncology|April 3, 2025
WHO Classification of Tumours: evolution of a global resource in the molecular eraJennelle C Hodge, George J Netto, Bharat Rekhi, et al.
JCI Insight|July 19, 2022
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitorsHasibur Rehman, Darshan S Chandrashekar, Chakravarthi Balabhadrapatruni, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2021
Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional ExperienceMaria Del Carmen Rodriguez Pena, Sofia Canete-Portillo, Ali Amin, et al.
The American Journal of Pathology|March 27, 2018
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate CancerMichael C Haffner, Gunes Guner, Diana Taheri, et al.
The American Journal of Surgical Pathology|June 23, 2025
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The ProstateKenneth A Iczkowski, Angelo M De Marzo, Neeraj Agarwal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate CancerSteven P Rowe, Kenneth L Gage, Sheila F Faraj, et al.
European Urology Oncology|October 9, 2023
Corrigendum to "Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes" [European Urology Oncology (2023)]Markus Eckstein, Christian Matek, Paul Wagner, et al.
Pageof 32

Showing results (271-280 of 315) with videos related to

Sort By:
Pageof 32
Archives of Pathology & Laboratory Medicine|August 4, 2006
Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experienceGeorge J Netto, David L Watkins, James W Williams, et al.
Histopathology|June 27, 2022
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancerJames G Kench, Mahul B Amin, Daniel M Berney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2010
A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancerAndrew J Armstrong, George J Netto, Michelle A Rudek, et al.
The Lancet. Oncology|April 3, 2025
WHO Classification of Tumours: evolution of a global resource in the molecular eraJennelle C Hodge, George J Netto, Bharat Rekhi, et al.
JCI Insight|July 19, 2022
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitorsHasibur Rehman, Darshan S Chandrashekar, Chakravarthi Balabhadrapatruni, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 10, 2021
Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional ExperienceMaria Del Carmen Rodriguez Pena, Sofia Canete-Portillo, Ali Amin, et al.
The American Journal of Pathology|March 27, 2018
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate CancerMichael C Haffner, Gunes Guner, Diana Taheri, et al.
The American Journal of Surgical Pathology|June 23, 2025
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The ProstateKenneth A Iczkowski, Angelo M De Marzo, Neeraj Agarwal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2015
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate CancerSteven P Rowe, Kenneth L Gage, Sheila F Faraj, et al.
European Urology Oncology|October 9, 2023
Corrigendum to "Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes" [European Urology Oncology (2023)]Markus Eckstein, Christian Matek, Paul Wagner, et al.
Pageof 32